Increasing Physical Activity in Persons With Depression
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02781688|
Recruitment Status : Completed
First Posted : May 24, 2016
Last Update Posted : October 30, 2017
|Condition or disease||Intervention/treatment||Phase|
|Depression Physical Activity||Behavioral: Physical Activity||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||25 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Increasing Physical Activity in Persons With Depression - Pilot|
|Actual Study Start Date :||January 2016|
|Actual Primary Completion Date :||July 2017|
|Actual Study Completion Date :||August 2017|
Experimental: Physical Activity Intervention
Participants will participate in a multi-component physical activity intervention for 12 weeks.
Behavioral: Physical Activity
Self-monitoring: Subjects will be provided with a commercially available activity monitor (i.e., Fitbit) and instructed to wear the device daily.
Active Living counseling: The Active Living counseling program will consists of 12 weekly group educational sessions, facilitated by project interventionists. These sessions will involve discussion of topics related to increasing physical activity, including: identifying and overcoming barriers, setting goals, social support, and time management.
Facility Access: Subjects will have access to the exercise lab in the UT Southwestern Depression Center consisting of equipment for aerobic exercise (treadmills, stationary bikes, etc.).
- Moderate-to-vigorous physical activity as measured by Actigraph accelerometer [ Time Frame: 12 weeks ]Assess changes in minutes of moderate-to-vigorous physical activity (MVPA) at 3 months following physical activity intervention.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02781688
|United States, Texas|
|UT Southwestern Medical Center|
|Dallas, Texas, United States, 75390|